WILMINGTON, N.C., June 13, 2011 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today it will participate in two investor conferences in June.
Ken Reali, President and Chief Executive Officer, is scheduled to present at the 2011 Wells Fargo Securities Healthcare Conference in Boston, MA on Wednesday, June 22, 2011 at 2:30 p.m. ET. Mr. Reali will discuss the Company and its progress toward gaining market share with its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. Mr. Reali will also conduct one-on-one meetings with institutional investors. Investors that wish to request a meeting with TranS1 should contact Wells Fargo Securities.
Joe Slattery, Executive Vice President and Chief Financial Officer, will participate in the Lazard Capital Markets Medical Technology Conference on Monday, June 20, 2011 at the Foxwoods Resort in Mashantucket, CT. The conference format consists of a full day of one-on-one meetings. Institutional investors that wish to request a meeting with TranS1 should contact Lazard Capital Markets.
About TranS1 Inc.
TranS1 is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single and multilevel lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina. For more information, visit www.trans1.com.
CONTACT: Investors: TranS1 Inc. Joseph P. Slattery, 910-332-1700 Executive Vice-President and Chief Financial Officer Westwicke Partners Mark Klausner, 443-213-0501 firstname.lastname@example.org